<DOC>
	<DOCNO>NCT02979691</DOCNO>
	<brief_summary>Ratiotherapy alone current standard treatment elderly esophageal esophagogastric cancer China . And Little known chemoradiotherapy ( CRT ) elderly patient . This study aim assess efficiency safety simultaneous integrate boost ( SIB ) intensity modulate radiation therapy ( IMRT ) S1 base SIB-IMRT follow adjuvant chemotherapy S1 elderly ( age ≥70 year ) esophageal esophagogastric cancer patient</brief_summary>
	<brief_title>Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy Elderly Patients With Esophageal Esophagogastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>≥70 year Esophageal Esophagogastric cancer Histologically proven squamous cell carcinoma adenocarcinoma patient stag IIaIVa ( UICC 2002 ) Karnofsky performance status ( KPS ) ≥ 70 Charlson score ≤3 No distant metastasis supraclavicular lymph nod No prior history thoracic radiation Patients must normal organ marrow function define : Leukocytes : great equal 3,500 G/L ; Platelets : great equal 100,000/mm3 .Hemoglobin : great equal 10g/L .Total bilirubin : within normal institutional limit ; AST/ALT : less equal 1.5 time upper limit ; Creatinine within normal upper limit Informed consent Patients cancer history except cervical carcinoma situ nonmalignant melanoma skin cancer With distant metastasis liver , lung , bone , CNS , etc History allergic reaction attribute similar chemical biologic complex S1 With esophageal fistula , perforation , cachexia prior treatment Uncontrolled illness include , limited , active infection , symptomatic heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness History myocardial infarction within past 6 month history ventricular arrhythmia Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>